Literature DB >> 29177917

MRI and multiple sclerosis--the evolving role of MRI in the diagnosis and management of MS: the radiologist's perspective.

Alexis M Cahalane1, Hugh Kearney2, Yvonne M Purcell3, Christopher McGuigan2, Ronan P Killeen3.   

Abstract

Magnetic resonance imaging (MRI) plays an integral role in the management of multiple sclerosis (MS), from both diagnostic and therapeutic perspectives. This 2-part review aims to detail the evolving and expanding role of MRI for both radiologists and neurologists. In this article, we discuss the diagnostic criteria for MS relevant to radiologists, as well as its varying imaging manifestations. The role of MRI in therapeutic modification and complications are discussed.

Entities:  

Keywords:  MRI; MS; PML; Radiology report

Mesh：

Year:  2017        PMID： 29177917     DOI： 10.1007/s11845-017-1714-9

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  49 in total

1.  Gadolinium Deposition after Contrast-enhanced MR Imaging.

Authors:  Tomonori Kanda; Megumi Matsuda; Hiroshi Oba; Keiko Toyoda; Shigeru Furui
Journal:  Radiology       Date:  2015-12       Impact factor: 11.105

2.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

Review 3.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

Review 4.  Established and novel disease-modifying treatments in multiple sclerosis.

Authors:  A H Cross; R T Naismith
Journal:  J Intern Med       Date:  2014-03-11       Impact factor: 8.989

Review 5.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

6.  Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities.

Authors:  Robert J McDonald; Jennifer S McDonald; David F Kallmes; Mark E Jentoft; Michael A Paolini; David L Murray; Eric E Williamson; Laurence J Eckel
Journal:  Radiology       Date:  2017-06-27       Impact factor: 11.105

7.  MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.

Authors:  Francois Cotton; Howard L Weiner; Ferenc A Jolesz; Charles R G Guttmann
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

8.  Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.

Authors:  Inês Brás Marques; Fernando Matias; Eduardo Duarte Silva; Luis Cunha; Lívia Sousa
Journal:  J Clin Neurosci       Date:  2013-08-23       Impact factor: 1.961

Review 9.  Treatment optimization in MS: Canadian MS Working Group updated recommendations.

Authors:  Mark S Freedman; Daniel Selchen; Douglas L Arnold; Alexandre Prat; Brenda Banwell; Michael Yeung; David Morgenthau; Yves Lapierre
Journal:  Can J Neurol Sci       Date:  2013-05       Impact factor: 2.104

10.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910
View more
  2 in total

1.  Quantitative magnetic resonance assessment of brain atrophy related to selected aspects of disability in patients with multiple sclerosis: preliminary results.

Authors:  Ewelina Marciniewicz; Anna Pokryszko-Dragan; Przemysław Podgórski; Krzysztof Małyszczak; Anna Zimny; Anna Kołtowska; Sławomir Budrewicz; Marek Sąsiadek; Joanna Bladowska
Journal:  Pol J Radiol       Date:  2019-04-02

2.  Neuroimaging Features and Associated Factors in Multiple Sclerosis Patients: A Perspective from a Private Care Center in Addis Ababa, Ethiopia.

Authors:  Biniyam A Ayele; Mehila Z Wuhib; Betesaida G Zenebe; Yared Z Zewde; Yonas T Wolde; Guta Z Metaferia
Journal:  Ethiop J Health Sci       Date:  2021-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.